As of 2025-08-08, the Intrinsic Value of Neuland Laboratories Ltd (NEULANDLAB.NS) is 3,947.37 INR. This NEULANDLAB.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 12,831.00 INR, the upside of Neuland Laboratories Ltd is -69.20%.
The range of the Intrinsic Value is 3,283.71 - 4,980.85 INR
Based on its market price of 12,831.00 INR and our intrinsic valuation, Neuland Laboratories Ltd (NEULANDLAB.NS) is overvalued by 69.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 3,283.71 - 4,980.85 | 3,947.37 | -69.2% |
| DCF (Growth 10y) | 5,524.86 - 8,417.75 | 6,663.22 | -48.1% |
| DCF (EBITDA 5y) | 9,242.02 - 12,656.59 | 10,510.07 | -18.1% |
| DCF (EBITDA 10y) | 11,318.16 - 16,628.43 | 13,358.09 | 4.1% |
| Fair Value | 5,068.35 - 5,068.35 | 5,068.35 | -60.50% |
| P/E | 4,829.13 - 7,245.34 | 5,961.31 | -53.5% |
| EV/EBITDA | 4,401.71 - 6,716.94 | 5,640.89 | -56.0% |
| EPV | 1,245.68 - 1,481.56 | 1,363.62 | -89.4% |
| DDM - Stable | 1,082.56 - 2,173.64 | 1,628.11 | -87.3% |
| DDM - Multi | 3,261.10 - 5,157.17 | 4,001.70 | -68.8% |
| Market Cap (mil) | 164,621.73 |
| Beta | 0.65 |
| Outstanding shares (mil) | 12.83 |
| Enterprise Value (mil) | 163,604.92 |
| Market risk premium | 8.31% |
| Cost of Equity | 14.75% |
| Cost of Debt | 7.81% |
| WACC | 14.67% |